130 related articles for article (PubMed ID: 11142693)
1. Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
D'Cruz OJ; Dong Y; Uckun FM
Anticancer Drugs; 2000 Nov; 11(10):849-58. PubMed ID: 11142693
[TBL] [Abstract][Full Text] [Related]
2. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
3. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
4. Bis(4,7-dimethyl and 5-dinitro-1,10-phenanthroline) sulfato-oxovanadium(IV)-mediated in vivo male germ cell apoptosis.
D'Cruz OJ; Uckun FM
J Appl Toxicol; 2001; 21(4):331-9. PubMed ID: 11481668
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
Dong Y; Narla RK; Sudbeck E; Uckun FM
J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
[TBL] [Abstract][Full Text] [Related]
6. DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.
Liao X; Lu J; Ying P; Zhao P; Bai Y; Li W; Liu M
J Biol Inorg Chem; 2013 Dec; 18(8):975-84. PubMed ID: 24077688
[TBL] [Abstract][Full Text] [Related]
7. Unsymmetrical oxovanadium complexes derived from salicylaldehyde and phenanthroline: synthesis, DNA interactions, and antitumor activities.
Liao X; Pan W; He R; Guo H; Ying P; Lu J
Chem Biol Drug Des; 2014 Mar; 83(3):367-78. PubMed ID: 24118856
[TBL] [Abstract][Full Text] [Related]
8.
Choroba K; Filipe B; Świtlicka A; Penkala M; Machura B; Bieńko A; Cordeiro S; Baptista PV; Fernandes AR
J Med Chem; 2023 Jul; 66(13):8580-8599. PubMed ID: 37311060
[TBL] [Abstract][Full Text] [Related]
9. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
10. Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.
D'Cruz OJ; Uckun FM
Expert Opin Investig Drugs; 2002 Dec; 11(12):1829-36. PubMed ID: 12457442
[TBL] [Abstract][Full Text] [Related]
11. Photocytotoxicity and DNA cleavage activity of L-arg and L-lys Schiff base oxovanadium(IV) complexes having phenanthroline bases.
Sasmal PK; Majumdar R; Dighe RR; Chakravarty AR
Dalton Trans; 2010 Aug; 39(30):7104-13. PubMed ID: 20563340
[TBL] [Abstract][Full Text] [Related]
12. Exploration of DNA binding mode, chemical nuclease, cytotoxic and apoptotic potentials of diketone based oxovanadium(IV) complexes.
Inamdar PR; Sheela A
Int J Biol Macromol; 2015 May; 76():269-78. PubMed ID: 25720830
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
14. Remarkable enhancement in photocytotoxicity and hydrolytic stability of curcumin on binding to an oxovanadium(IV) moiety.
Banerjee S; Pant I; Khan I; Prasad P; Hussain A; Kondaiah P; Chakravarty AR
Dalton Trans; 2015 Mar; 44(9):4108-22. PubMed ID: 25623080
[TBL] [Abstract][Full Text] [Related]
15. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
16. Synthetic analogs for oxovanadium(IV/V)-glutathione interaction: an NMR, EPR, synthetic and structural study of oxovanadium(IV/V) compounds with sulfhydryl-containing pseudopeptides and dipeptides.
Tasiopoulos AJ; Troganis AN; Deligiannakis Y; Evangelou A; Kabanos TA; Woollins JD; Slawin A
J Inorg Biochem; 2000 Apr; 79(1-4):159-66. PubMed ID: 10830861
[TBL] [Abstract][Full Text] [Related]
17. DNA cleavage by new oxovanadium(IV) complexes of N-salicylidene alpha-amino acids and phenanthroline bases in the photodynamic therapy window.
Sasmal PK; Patra AK; Nethaji M; Chakravarty AR
Inorg Chem; 2007 Dec; 46(26):11112-21. PubMed ID: 18020327
[TBL] [Abstract][Full Text] [Related]
18. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
[TBL] [Abstract][Full Text] [Related]
19. Complexes of cis-dioxomolybdenum(VI) and oxovanadium(IV) with a tridentate ONS donor ligand: synthesis, spectroscopic properties, X-ray crystal structure and catalytic activity.
Fayed AM; Elsayed SA; El-Hendawy AM; Mostafa MR
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():293-302. PubMed ID: 24747851
[TBL] [Abstract][Full Text] [Related]
20. [Anticancer activity of oxovanadium compounds].
Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
